Nanomedicine and Nanoscale Delivery (Focus Group – NND)

Riku Kawasaki, Ph. D.
Associate Professor
Hiroshima University
Higashi Hiroshima, Japan
With minimal invasiveness, BNCT is considered a promising modality for cancer treatment. BNCT selectively eradicates cancer cells through lethal DNA damage induced by highly cytotoxic α-particles and lithium nuclei generated from the nuclear reaction between neutrons and boron-10. Efficient intracellular delivery of boron agents is essential to maximize therapeutic efficacy. Although clinically used agents such as boronophenylalanine (BPA) and sodium borocaptate (BSH) are available, limitations in tumor selectivity and cellular accumulation remain [1]. Here, we developed a self-assembled system incorporating hydrophobic carborane to improve boron delivery efficiency.